- Home
- CUTR vs ADIL Comparison
CUTR vs ADIL Comparison
Compare CUTR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUTR
- ADIL
- Stock Information
- Founded
- CUTR 1988
- ADIL 2010
- Country
- CUTR United States
- ADIL United States
- Employees
- CUTR N/A
- ADIL N/A
- Industry
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- CUTR Health Care
- ADIL Health Care
- Exchange
- CUTR Nasdaq
- ADIL Nasdaq
- Market Cap
- CUTR 7.3M
- ADIL 6.5M
- IPO Year
- CUTR 2004
- ADIL 2018
- Fundamental
- Price
- CUTR $0.32
- ADIL $1.01
- Analyst Decision
- CUTR Hold
- ADIL Strong Buy
- Analyst Count
- CUTR 3
- ADIL 1
- Target Price
- CUTR $3.00
- ADIL $8.00
- AVG Volume (30 Days)
- CUTR 433.8K
- ADIL 200.5K
- Earning Date
- CUTR 11-07-2024
- ADIL 11-13-2024
- Dividend Yield
- CUTR N/A
- ADIL N/A
- EPS Growth
- CUTR N/A
- ADIL N/A
- EPS
- CUTR N/A
- ADIL N/A
- Revenue
- CUTR $155,210,000.00
- ADIL N/A
- Revenue This Year
- CUTR N/A
- ADIL N/A
- Revenue Next Year
- CUTR $4.81
- ADIL N/A
- P/E Ratio
- CUTR N/A
- ADIL N/A
- Revenue Growth
- CUTR N/A
- ADIL N/A
- 52 Week Low
- CUTR $0.28
- ADIL $0.77
- 52 Week High
- CUTR $4.97
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- CUTR 24.65
- ADIL 47.97
- Support Level
- CUTR $0.36
- ADIL $0.99
- Resistance Level
- CUTR $0.63
- ADIL $1.28
- Average True Range (ATR)
- CUTR 0.05
- ADIL 0.06
- MACD
- CUTR -0.01
- ADIL -0.00
- Stochastic Oscillator
- CUTR 10.46
- ADIL 12.90
About CUTR Cutera Inc.
Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.